Picture of Stratec SE logo

SBS Stratec SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Brief: Stratec With FY Adjusted EBITDA Margin Of 15.9%

March 28 (Reuters) - STRATEC SE  SBSG.DE :
    * STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR
    * STRATEC SE - CONSOLIDATED SALES IN 2023 -3.8% AT CONSTANT
CURRENCY TO EUR 261.9 MILLION (2022: EUR 274.6 MILLION)
    * STRATEC SE - ADJUSTED EBIT MARGIN OF 10.3% (2022: 16.4%)
WITHIN
GUIDANCE CORRIDOR
    * STRATEC SE - 2024 GUIDANCE: SALES ON A CONSTANT-CURRENCY
BASIS
EXPECTED TO REMAIN STABLE OR GROW SLIGHTLY WITH ADJUSTED EBIT
MARGIN OF AROUND 10.0% TO 12.0%
    * STRATEC SE - VERY WEAK START TO YEAR, WITH STRONG RECOVERY
IN
SALES AND EARNINGS PERFORMANCE EXPECTED FROM Q2 OF 2024
    * STRATEC SE - STRATEC GENERATED CONSOLIDATED SALES OF EUR
261.9
MILLION IN 2023 FINANCIAL YEAR (PREVIOUS YEAR: EUR 274.6
MILLION)
    * STRATEC SE - BOARD OF MANAGEMENT AND SUPERVISORY BOARD
PLAN TO
PROPOSE DISTRIBUTION OF A DIVIDEND OF EUR 0.55 PER SHARE FOR
2023 FINANCIAL YEAR FOR APPROVAL BY ANNUAL GENERAL MEETING ON
MAY 17, 2024 (PREVIOUS YEAR: EUR 0.97 PER SHARE)
    * STRATEC SE - ADJUSTED EBITDA MARGIN OF 15.9%

Source text for Eikon:  ID:nEQ1qDNZ7a 
Further company coverage:  SBSG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Stratec SE

See all news